Title: CRISPR/Cas-mediated APOC3 Knockout as a One-time Treatment for Severe Hypertriglyceridemia Presenters: Alan Brooks, PhD, Senior Vice President of Research at Metagenomi Date/time: Monday, ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
CRISPR-based diagnostics offer rapid and highly sensitive detection of disease biomarkers. Their ease of use and compatibility with lateral-flow readouts make them suitable for point-of-care ...
Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...
News-Medical.Net on MSN
CRISPR-based Cellgorithm technology ushers in a new era of cell programming
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback